The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125795584 12579558 4 F 20160831 20160721 20160912 EXP GB-CIPLA LTD.-2016GB09864 CIPLA 0.00 Y 0.00000 20160912 OT GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125795584 12579558 1 PS SERTRALINE SERTRALINE HYDROCHLORIDE 1 Oral 50 MG, WITHDRAWN BEFORE 13-JUN-2016 Y U 77397 50 MG
125795584 12579558 2 C ASPIRIN. ASPIRIN 1 Oral 75 MG, UNK U U 0 75 MG
125795584 12579558 3 C Atorvastatin ATORVASTATIN 1 Oral 40 MG U U 0 40 MG
125795584 12579558 4 C LANSOPRAZOLE. LANSOPRAZOLE 1 Oral 15 MG, AS NECESSARY (PRN BASIS) U U 0 15 MG
125795584 12579558 5 C LISINOPRIL. LISINOPRIL 1 Oral 20 MG, UNK U U 0 20 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125795584 12579558 1 Stress
125795584 12579558 2 Prophylaxis
125795584 12579558 3 Prophylaxis
125795584 12579558 5 Hypertension

Outcome of event

Event ID CASEID OUTC COD
125795584 12579558 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125795584 12579558 Amnesia
125795584 12579558 Anger
125795584 12579558 Asthenia
125795584 12579558 Decreased appetite
125795584 12579558 Diarrhoea
125795584 12579558 Disturbance in attention
125795584 12579558 Dizziness postural
125795584 12579558 Dyskinesia
125795584 12579558 Eye pain
125795584 12579558 Haemorrhage subcutaneous
125795584 12579558 Headache
125795584 12579558 Heart rate increased
125795584 12579558 Mental disorder
125795584 12579558 Nausea
125795584 12579558 Palpitations
125795584 12579558 Psychiatric symptom
125795584 12579558 Somnolence
125795584 12579558 Thinking abnormal
125795584 12579558 Tinnitus
125795584 12579558 Vertigo

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125795584 12579558 1 20160602 0
125795584 12579558 2 20141113 0
125795584 12579558 3 20141223 0
125795584 12579558 4 20160125 0
125795584 12579558 5 20150402 0